Lynette Herscha, J.D.
Chief Legal Officer
Senda Biosciences

Lynette has more than 20 years of experience in various leadership roles in the technology and biopharma industry. 

Prior to joining Senda, she served as Chief Legal Officer for Solid Biosciences where she oversaw all aspects of Solid’s legal affairs, including corporate governance, securities reporting, intellectual property and compliance. Prior to her tenure at Solid, she served as the General Counsel for Concert Pharmaceuticals, a company pioneering the use of deuterium chemistry to develop new medicines. Before joining Concert, Lynette held various senior legal positions at Momenta Pharmaceuticals, Inc., a public biotechnology company, and Phase Forward, Inc., a public technology company. She began her career at the law offices of Fulbright & Jaworski. 

Lynette holds a J.D. from Boston University School of Law and a B.A. from Boston University.